Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy
- Conditions
- Acute Leukemia
- Registration Number
- NCT03279900
- Lead Sponsor
- Indonesia University
- Brief Summary
This study use an observational study design from patient medical records to obtain data on patient demographics, nutritional status, 6MP dosing, and albumin levels of LLA child patients.
- Detailed Description
All medical record data of LLA child patient at maintenance phase therapy, who came to Cipto Mangunkusumo Kiara Hospital in period 2014 - 2016. the data that are colected consist of age, gender, disease stratification, nutritional status, the dosage of 6-MP, albumin levels, hemoglobin levels, leukocyite counts, platelet counts, and absolute neutrophil counts.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
- LLA Patients, male and female, age 1 - <18 years
- Received chemotherapy maintenance phase based on Indonesian protocol of ALL - 2013
- Incomplete medical record data.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Incidence of hematotoxicity in acute limphoblastic leukemia children during maintenance phase therapy. october 2017 based on medical record data: Incidence of anemia, Neutropenia, and thrombocytopenia in acute limphoblastic leukemia children during maintenance phase therapy.
- Secondary Outcome Measures
Name Time Method The relationship of the incidence of hematotoxicity with influencing factors November 2017 The relationship of the incidence of hematotoxicity (anemia, Neutropenia, thrombocitopenia) with ALL stratification (High risk or Standard risk, as written in the medical record), nutritional status (normal or malnutrition), and albumin levels (normal or Hypoalbuminemia). The determination of nutritional status is based on body weight (Kg) and Height (Meters). Determination of nutritional status using cutoff Z score based on The growth chart of WHO 2006 for children 0-5 years, and ideal weight percentage according to Waterlow criteria for children above 5 years (recommendation of Indonesian Pediatric Association).
Trial Locations
- Locations (1)
Cipto Mangunkusomo hospital
🇮🇩Jakarta Pusat, Jakarta, Indonesia